Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios for Predicting Malignant Potential of Suspicious Ovarian Masses in Gynecology Practice

  • Topcu, Hasan Onur (Obstetrics and Gynecology, Medicine, Dr Zekai Tahir Burak Women's Health Education and Research Hospital) ;
  • Guzel, Ali Irfan (Obstetrics and Gynecology, Medicine, Dr Zekai Tahir Burak Women's Health Education and Research Hospital) ;
  • Ozer, Irfan (Obstetrics and Gynecology, Medicine, Dr Zekai Tahir Burak Women's Health Education and Research Hospital) ;
  • Kokanali, Mahmut Kuntay (Obstetrics and Gynecology, Medicine, Dr Zekai Tahir Burak Women's Health Education and Research Hospital) ;
  • Gokturk, Umut (Karamursel State Hospital) ;
  • Muftuoglu, Kamil Hakan (Department of Pathology, Dr Zekai Tahir Burak Women's Health Education and Research Hospital) ;
  • Doganay, Melike (Karamursel State Hospital)
  • Published : 2014.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To compare the diagnostic accuracy of the neutrophil/lymphocyte ratio (NLR) with the platelet/lymphocyte ratio (PLR) in predicting malignancy of pelvic masses which are pre-operatively malignant suspicious. Materials and Methods: In this retrospective study we evaluated the clinical features of patients with ovarian masses which had pre-operatively been considered suspicious for malignancy. The patients whose intraoperative frozen sections were malign were classified as the study group, while those who had benign masses were the control group. Data recorded were age of the patient, diameter of the mass, pre-operative serum Ca 125 levels, platelet count, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Results: There was statistically significantly difference between the groups in terms of age, diameter of the mass, serum Ca 125 levels, platelet number and platelet/lymphocyte ratio. Mean neutrophil/lymphocyte ratios showed no difference between the groups. ROC curve analysis showed that age, serum Ca 125 levels, platelet number and PLR were discriminative markers in predicting malignancy in adnexal masses. Conclusions: According to the current study, serum Ca 125 levels, pre-operative platelet number and PLR may be good prognostic factors, while NLR is an ineffective marker in predicting the malignant characteristics of a pelvic mass.

Keywords

References

  1. Acmaz G, Aksoy H, Unal D, et al (2014). Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev, 15, 1689-92. https://doi.org/10.7314/APJCP.2014.15.4.1689
  2. Arab M, Yaseri M, Ashrafganjoi T, et al (2012). Comparison of two ovarian malignancy prediction models based on age sonographic findings and serum CA125 measurement. Asian Pac J Cancer Prev, 13, 4199-202. https://doi.org/10.7314/APJCP.2012.13.8.4199
  3. Ashrafgangooei T, Rezaeezadeh M (2011). Risk of malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev, 12, 1727-30.
  4. Balik G, Kagitci M, Ustuner I, et al (2013). Which endometrial pathologies need intraoperative frozen sections? Asian Pac J Cancer Prev, 14, 6121-5. https://doi.org/10.7314/APJCP.2013.14.10.6121
  5. Covens AL, Dodge JE, Lacchetti C, et al (2012). Gynecology Cancer Disease Site Group. Surgical management of a suspicious adnexal mass: a systematic review. Gynecol Oncol, 126, 149-56. https://doi.org/10.1016/j.ygyno.2012.04.018
  6. Gal AA, Cagle PT (2005). The 100-year anniversary of the description of the frozen section procedure. JAMA, 294, 3135-7. https://doi.org/10.1001/jama.294.24.3135
  7. Ganesan R, Brown LJ, Kehoe S, et al (2013). The role of frozen sections in gynaecological oncology: survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol, 166, 204-8. https://doi.org/10.1016/j.ejogrb.2012.10.024
  8. Hafeez S, Sufian S, Beg M, et al (2013). Role of ultrasound in characterization of ovarian masses. Asian Pac J Cancer Prev, 14, 603-6. https://doi.org/10.7314/APJCP.2013.14.1.603
  9. Halazun KJ, Hardy MA, Rana AA, et al (2009). Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg, 250, 141-51. https://doi.org/10.1097/SLA.0b013e3181a77e59
  10. Hernandez E, Donohue KA, Anderson LL, et al (2000). The significance of thrombocytosis in cases with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol, 78, 137-42. https://doi.org/10.1006/gyno.2000.5838
  11. Jacobs I, Oram D, Fairbanks J, et al (1990). A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 97, 922-9. https://doi.org/10.1111/j.1471-0528.1990.tb02448.x
  12. Kuyumcuoglu U, Guzel AI, Celik Y, et al (2010). The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol, 31, 514-6.
  13. Myers ER, Bastian LA, Havrilesky LJ, et al (2006). Management of adnexal mass. Evid Rep Technol Assess, 130, 1-145.
  14. Shih KK, Garg K, Soslow RA, et al (2011). Accuracy of frozen section diagnosis of ovarian borderline tumor. Gynecol Oncol, 123, 517-21. https://doi.org/10.1016/j.ygyno.2011.08.013
  15. Suprasert P, Khunamornpong S, Phusong A, et al (2008). Accuracy of intra-operative frozen sections in the diagnosis of ovarian masses. Asian Pac J Cancer Prev, 9, 737-40
  16. Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40. https://doi.org/10.1046/j.1525-1438.2001.01024.x
  17. Yang H, Zhu L, Wang S, et al (2013). Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125. J Minim Invasive Gynecol, 10, 300-2.

Cited by

  1. Relations of Platelet Indices with Endometrial Hyperplasia and Endometrial Cancer vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4905
  2. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5933
  3. Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors? vol.9, pp.1, 2016, https://doi.org/10.1186/s13048-016-0283-2
  4. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis vol.20, pp.5, 2017, https://doi.org/10.1080/13697137.2017.1326894